×

Delivery of immune response modifier compounds

  • US 8,961,477 B2
  • Filed: 08/25/2004
  • Issued: 02/24/2015
  • Est. Priority Date: 08/25/2003
  • Status: Active Grant
First Claim
Patent Images

1. A method for the delivery of an immune response modifier (IRM) compound into or across a biological barrier comprising:

  • contacting a biological barrier with a microneedle device comprising at least one microneedle;

    administering at least one IRM compound selected from the group consisting of amide substituted imidazoquinoline amines, sulfonamide substituted imidazoquinoline amines, urea substituted imidazoquinoline amines, aryl ether substituted imidazoquinoline amines, heterocyclic ether substituted imidazoquinoline amines, amido ether substituted imidazoquinoline amines, sulfonamido ether substituted imidazoquinoline amines, urea substituted imidazoquinoline ethers, thioether substituted imidazoquinoline amines, and 2-propyl[1,3]thiazolo[4,5-c]quinolin-4-amine;

    a pharmaceutically acceptable salt thereof; and

    combinations thereof, into or across the biological barrier; and

    administering a vaccine;

    wherein the vaccine is a protein, glycoprotein, or peptide vaccine; and

    wherein the IRM compound is chemically linked to the vaccine and both the IRM compound and the vaccine are coated onto at least a portion of the microneedle device.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×